Obenshain Andrew 4
4 · bluebird bio, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Obenshain Andrew
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-01-06$9.24/sh−140$1,294→ 18,571 total
Footnotes (2)
- [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F2]The number of securities reported herein have been adjusted to reflect a 1-for-20 reverse stock split effected by the Issuer on December 12, 2024.